Reassessing NSF Risk with Modern Contrast
Автор: RadiologyRSNA
Загружено: 2026-03-03
Просмотров: 44
Описание:
Dr. Lauren Kim speaks with Adarsh Mallepally and Dr. Cory Trankle about their large-scale retrospective study of nearly 4 million patients examining the risk of nephrogenic systemic fibrosis after gadolinium-based contrast administration in those with advanced renal dysfunction. They discuss how modern group 2 and macrocyclic agents were associated with an exceedingly low incidence of NSF, offering important reassurance for evidence-based contrast use and evolving clinical practice.
Nephrogenic Systemic Fibrosis in Patients with Advanced RenalDysfunction Following Gadolinium-based Contrast Agents. Mallepally et al. Radiology 2025; 317(3):e251794. (https://doi.org/10.1148/radiol.251794)
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
